Literature DB >> 8415722

The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients.

C Pujol1, J Reynes, F Renaud, M Raymond, M Tibayrenc, F J Ayala, F Janbon, M Mallié, J M Bastide.   

Abstract

To ascertain the population structure of Candida albicans, we have carried out a multilocus enzyme electrophoresis study based on the analysis of 21 gene loci. We have thus characterized 55 strains isolated one each from 55 human immunodeficiency virus-positive patients. There is considerable polymorphism among the strains. A population-genetic analysis indicates that the two fundamental consequences of sexual reproduction (i.e., segregation and recombination) are apparently absent in this population of C. albicans. The population structure of C. albicans appears to be clonal, a state of affairs that has important medical and biological consequences.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8415722      PMCID： PMC47587          DOI： 10.1073/pnas.90.20.9456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  19 in total

1.  Physical and genetic mapping of Candida albicans: several genes previously assigned to chromosome 1 map to chromosome R, the rDNA-containing linkage group.

Authors:  B Wickes; J Staudinger; B B Magee; K J Kwon-Chung; P T Magee; S Scherer
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

2.  Population structure of multilocus associations.

Authors:  A H Brown; M W Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

Review 3.  Population genetics of pathogenic bacteria.

Authors:  R K Selander; J M Musser; D A Caugant; M N Gilmour; T S Whittam
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

4.  Are eukaryotic microorganisms clonal or sexual? A population genetics vantage.

Authors:  M Tibayrenc; F Kjellberg; J Arnaud; B Oury; S F Brenière; M L Dardé; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Epidemiological analysis of Candida albicans strains by multilocus enzyme electrophoresis.

Authors:  D A Caugant; P Sandven
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Heterozygosity and segregation in Candida albicans.

Authors:  W L Whelan; R M Partridge; P T Magee
Journal:  Mol Gen Genet       Date:  1980

7.  Isoenzyme biotypes of Candida species.

Authors:  P F Lehmann; B J Kemker; C B Hsiao; S Dev
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

8.  Hybrid formation between African trypanosomes during cyclical transmission.

Authors:  L Jenni; S Marti; J Schweizer; B Betschart; R W Le Page; J M Wells; A Tait; P Paindavoine; E Pays; M Steinert
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

9.  Recombination analysis of naturally diploid Candida albicans.

Authors:  R Poulter; V Hanrahan; K Jeffery; D Markie; M G Shepherd; P A Sullivan
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

10.  Genetic diversity and structure in Escherichia coli populations.

Authors:  R K Selander; B R Levin
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728
View more
  70 in total

1.  Multilocus genotypes and DNA fingerprints Do not predict variation in azole resistance among clinical isolates of Candida albicans.

Authors:  L E Cowen; C Sirjusingh; R C Summerbell; S Walmsley; S Richardson; L M Kohn; J B Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450.

Authors:  K Asai; N Tsuchimori; K Okonogi; J R Perfect; O Gotoh; Y Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Rad52 function prevents chromosome loss and truncation in Candida albicans.

Authors:  E Andaluz; A Bellido; J Gómez-Raja; A Selmecki; K Bouchonville; R Calderone; J Berman; G Larriba
Journal:  Mol Microbiol       Date:  2011-01-27       Impact factor: 3.501

6.  Genotyping of Candida albicans oral strains from healthy individuals by polymorphic microsatellite locus analysis.

Authors:  Frédéric Dalle; Laure Dumont; Norélie Franco; David Mesmacque; Denis Caillot; Pierre Bonnin; Caroline Moiroux; Odile Vagner; Bernadette Cuisenier; Sarab Lizard; Alain Bonnin
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Skin facilitates Candida albicans mating.

Authors:  Salil A Lachke; Shawn R Lockhart; Karla J Daniels; David R Soll
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade.

Authors:  Claude Pujol; Michael Pfaller; David R Soll
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Genetic diversity among clinical isolates of Candida glabrata analyzed by randomly amplified polymorphic DNA and multilocus enzyme electrophoresis analyses.

Authors:  Xavier M Boldo; Lourdes Villa-Tanaca; Gerardo Zúñiga; César Hernández-Rodríguez
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 10.  The evolution of sex: a perspective from the fungal kingdom.

Authors:  Soo Chan Lee; Min Ni; Wenjun Li; Cecelia Shertz; Joseph Heitman
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.